Literature DB >> 19461497

Exhaled carbon monoxide as a noninvasive marker of airway neutrophilia after lung transplantation.

Robin Vos1, Colin Cordemans, Bart M Vanaudenaerde, Stéphanie I De Vleeschauwer, Annemie Schoonis, Dirk E Van Raemdonck, Lieven J Dupont, Geert M Verleden.   

Abstract

BACKGROUND: Neutrophilic airway inflammation and associated oxidative stress contribute to airway injury and the development of bronchiolitis obliterans syndrome after lung transplantation (LTx). Exhaled carbon monoxide (eCO) reflects heme oxygenase-1 activity in response to oxidative stress. We investigated whether airway neutrophilia and eCO levels are associated in stable LTx recipients.
METHODS: In this cross-sectional pilot study, 45 stable LTx recipients were included. During routine follow-up at the outpatient clinic, pulmonary function testings together with eCO measurements before broncho-alveolar lavage (BAL) were performed. BAL cell differentials and interleukin (IL)-8 protein levels were assessed and correlated with eCO.
RESULTS: In the studied cohort, eCO levels were increased in patients with elevated (>3%) BAL neutrophilia compared with those with normal BAL neutrophilia (P=0.025). Furthermore, eCO levels significantly correlated with BAL neutrophilia and IL-8 levels in the cohort as a whole (r=0.50; P=0.0005 for total cells, r=0.43; P=0.003 for %cells and r=0.30; P=0.045 for IL-8). This was even more obvious in the LTx recipients with increased (>3%) BAL neutrophilia (r=0.70; P=0.0007 for total cells and r=0.80; P<0.0001 for %cells). For a cutoff of 4 ppm, sensitivity, specificity, positive and negative predictive value of eCO for detecting elevated BAL neutrophilia were 84.0%, 45.0%, 65.6%, and 69.2%, respectively (P=0.049).
CONCLUSIONS: Elevated eCO levels in stable LTx recipients may reflect an increased BAL neutrophilia and could, therefore, be used as a noninvasive marker for airway inflammation after LTx.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19461497     DOI: 10.1097/TP.0b013e3181a4e69c

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Continuous Endogenous Exhaled CO Monitoring by Laser Spectrometer in Human EVLP Before Lung Transplantation.

Authors:  Vivien Brenckmann; Raphael Briot; Irène Ventrillard; Daniele Romanini; Maud Barbado; Kevin Jaulin; Candice Trocme; Julien De Wolf; Matthieu Glorion; Édouard Sage
Journal:  Transpl Int       Date:  2022-05-31       Impact factor: 3.842

Review 2.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

3.  Friend or foe? Carbon monoxide and the mitochondria.

Authors:  Nils Schallner; Leo E Otterbein
Journal:  Front Physiol       Date:  2015-02-03       Impact factor: 4.566

4.  Normal values of exhaled carbon monoxide in healthy subjects: comparison between two methods of assessment.

Authors:  Umberto Moscato; Andrea Poscia; Riccardo Gargaruti; Giovanni Capelli; Franco Cavaliere
Journal:  BMC Pulm Med       Date:  2014-12-16       Impact factor: 3.317

Review 5.  Chronic allograft dysfunction.

Authors:  Christiane Knoop; Marc Estenne
Journal:  Clin Chest Med       Date:  2011-06       Impact factor: 2.878

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.